Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Pulse Biosciences Inc (PLSE)

93 + Investors. Track Smart Money conviction in PLSE. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +14
Streak
1Q ▲
Buyers last Q
58%

Smart Money Signals — PLSE

Based on 93 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added PLSE than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
93 hedge funds hold PLSE right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +13% more funds vs a year ago

fund count last 6Q
+11 new funds entered over the past year (+13% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 58% buying

57 buying42 selling
Last quarter: 57 funds bought or added vs 42 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
📈

More new buyers each quarter (+21 vs last Q)

new funds entering per quarter
Funds opening a new PLSE position: 12 → 9 → 10 → 31. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

46% of holders stayed for 2+ years

46% conviction (2yr+) 20% medium 33% new
43 out of 93 hedge funds have held PLSE for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +93% but shares only +23% — price-driven

Value
+93%
Shares
+22%
Last quarter: the total dollar value of institutional holdings rose +93%, but actual share count only changed +23%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
🚀

Acceleration phase — new buyers rushing in

19 → 12 → 9 → 10 → 31 new funds/Q
New funds entering each quarter: 12 → 9 → 10 → 31. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Veteran-anchored — 49% veterans vs 35% newcomers

49% veterans 16% 1-2yr 35% new
Entry-cohort mix of 96 holders: 47 (49%) are 2+ year veterans, 15 entered 1–2 years ago, and 34 (35%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 42% AUM from top-100 funds

42% from top-100 AUM funds
31 of 93 holders are among the 100 largest funds by AUM, controlling 42% of total institutional value in PLSE. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.9
out of 10
Low Exit Risk
Exit risk score 3.9/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — PLSE

In 2026 Q1, 57 hedge funds were net buyers of PLSE (31 opened a new position, 26 added to an existing one), while 42 reduced or exited (25 trimmed, 17 sold completely) — a 58% buyer ratio, indicating a slight buying edge. 42% of total institutional value in PLSE is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +14 funds (more new holders than closures). Total institutional holders: 93.

Hedge Fund Ownership: PLSE

How many hedge funds hold PLSE — quarterly history vs. share price
Quarterly hedge fund ownership of PLSE vs. share price

Market Analysis: PLSE

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: PLSE

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Pulse Biosciences Inc (PLSE) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much PLSE has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 79d ago
PLSE
+22.4%
XLV
+1.6%

PLSE outperformed XLV by +20.8% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 34d ago
PLSE
+7.6%
XLV
+2.6%

Since the filing became public, PLSE outperformed XLV by +5.0% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

13 top-rated funds 0 high-conviction
Consensus
5.0
/ 10
breadth
×
Elite
0.7
/ 10
conviction
Hedge Fund Positioning: PLSE
93 + Investors

Track Smart Money conviction in PLSE. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 93 79 17.72%
13F Shares 8M 6M 22.94%
Total Value $169M $87M 93.15%
New Positions 31 10 +21
Increased Positions 26 23 +3
Closed Positions 17 12 +5
Reduced Positions 23 29 -6
Total Calls 2 1 100.0%
Total Puts 1 1 -
PUT/CALL Ratio 0.5 1.0 Bullish

Statistics: PLSE

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

93 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in PLSE. Verified SEC 13F-HR filings.

QUARTER:
Top 25 PLSE holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Panoramic Capital, LLC 0.88% 58,054 $1.3M
2 Portolan Capital Management, LLC 0.84% 733,372 $15.8M
3 Griffin Asset Management, INC. 0.55% 225,177 $4.9M
4 Diker Management LLC 0.37% 19,000 $410K
5 Argo Wealth Advisory, LLC 0.36% 28,156 $608K
6 Formula Growth Ltd 0.29% 30,000 $648K
7 Westside Investment Management, Inc. 0.23% 70,492 $1.5M
8 WealthTrust Axiom LLC 0.11% 21,500 $464K
9 Parkman Healthcare Partners LLC 0.11% 50,125 $1.1M
10 Bender Robert & Associates 0.06% 12,190 $263K
11 Inspire Investing, LLC 0.04% 24,274 $524K
12 LMR Partners LLP 0.01% 213,137 $4.6M
13 XTX Topco Ltd 0.01% 23,841 $515K
14 Balyasny Asset Management L.P. 0.01% 265,164 $5.7M
15 Brooklyn Investment Group 0.01% 10,470 $226K
16 AlphaQuest LLC 0.01% 8,864 $122K
17 Allstate Corp 0.01% 23,468 $507K
18 Massachusetts Financial Services Co /Ma/ 0.00% 462,899 $10.0M
19 Farther Finance Advisors, LLC 0.00% 12,160 $280K
20 Brevan Howard Capital Management LP 0.00% 12,164 $263K
21 Tiaa-Cref Individual & Institutional Services, LLC 0.00% 27,298 $589K
22 Bank of America Corp /de/ 0.00% 866,061 $18.7M
23 Tower Research Capital LLC (TRC) 0.00% 2,416 $52K
24 Osterweis Capital Management Inc 0.00% 1,000 $22K
25 MetLife Investment Management, LLC 0.00% 9,794 $211K
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Pulse Biosciences Inc (PLSE)

What does the Smart Money Trend signal show for PLSE?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added PLSE than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for PLSE?

Slight buying edge — 58% buying: Last quarter: 57 funds bought or added vs 42 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for PLSE holders?

Elite ownership — 42% AUM from top-100 funds: 31 of 93 holders are among the 100 largest funds by AUM, controlling 42% of total institutional value in PLSE. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held PLSE?

46% of holders stayed for 2+ years: 43 out of 93 hedge funds have held PLSE for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Pulse Biosciences Inc (PLSE) following the 2026 Q1 hedge fund 13F filings?

As of today, PLSE has moved +7.6% since the 2026 Q1 13F filing date (May 15, 2026), compared to +2.6% for the XLV sector ETF — an outperformance of +5.0%. Since the quarter end (March 31, 2026), PLSE has gained +22.4% vs +1.6% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →